NextCure, Inc.

New Filing
CIK: 0001661059·Biotechnology·DELAWARE·Filed: Jan 11, 2016
Total Offering

$67,000,000

Amount Sold

$15,000,000

Investors

7

First Sale

Dec 29, 2015

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired, Other: Series A Preferred Stock and the Common Stock issuable upon the conversion thereof
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2015
Non-Accredited Investors
No

Related Persons

NameRole
MICHAEL RICHMAN
Related Person
ASHER RUBIN
Related Person
DAVID KABAKOFF
Related Person
CAROLYN GREEN
Related Person
CHAU Q. KHUONG
Related Person
TIM SHANNON
Related Person
JUDITH LI
Related Person

Company

NextCure, Inc.

13503 SANDERLING PLACE

GERMANTOWN, MD, 20874

240-418-1773

SEC Filing

0001140361-16-047469

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
NextCure, Inc. Form D Filing — $67,000,000 | FilingFlow